Atlas Trials

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

Clinical trial NCT03387514 · TERMINATED

Trial details

NCT number
NCT03387514
Sponsor
University of Wisconsin, Madison
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2018-12-08
Primary completion
2021-06-29
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.